Imogen Mansfield

Stock Analyst at Cantor Fitzgerald

(n/a)
# 5,164
Out of 5,182 analysts
1
Total ratings
n/a
Success rate
-29.97%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Imogen Mansfield

Eikon Therapeutics
Mar 2, 2026
Initiates: Overweight
Price Target: n/a
Current: $9.90
Upside: -